New COVID variant 'R.1' with increased resistance to antibodies is identified at Kentucky nursing home where 45 residents and workers have fallen sick
The mutant strain - dubbed R.1 - is a variant to watch according to former Harvard Medical School professor Dr William Haseltine. There have been 10,000 cases worldwide.
(More on the link)
.
“We now have generated evidence that a booster shot further increases protection against Covid-19 and is expected to extend the duration of protection significantly,” said Paul Stoffels, chief scientific officer at J&J. The company said it has shared available data with the Food and Drug Administration.
The late-stage study tested a two-dose regimen of the vaccine in about 32,000 people aged 18 and over in the U.S., Belgium, Brazil, Colombia, France, Germany, the Philippines, South Africa, Spain and the U.K., J&J said. The company said about half of participants received the placebo but didn’t say how many participants were in the U.S.
Johnson & Johnson said a booster dose of its Covid-19 vaccine administered two months after the first shot increased protection against symptomatic illness in trial participants, as federal regulators evaluate data for the country’s strategy for rolling out boosters.
Data released Tuesday from a late-stage clinical trial showed that study participants in 10 countries including the U.S. who received a second dose of the company’s vaccine two months after the first had 75% protection against symptomatic Covid-19. Participants in the U.S. had 94% protection against the illness. J&J didn’t explain the reason for the difference in efficacy rates.
A double dose of the vaccine provided participants with 100% protection against severe or critical Covid-19 at least two weeks after the second shot, J&J said.
The company earlier this year said a large clinical trial showed that a single dose of its vaccine was 66% effective at protecting people from moderate to severe Covid-19.
“We now have generated evidence that a booster shot further increases protection against Covid-19 and is expected to extend the duration of protection significantly,” said Paul Stoffels, chief scientific officer at J&J. The company said it has shared available data with the Food and Drug Administration.
The late-stage study tested a two-dose regimen of the vaccine in about 32,000 people aged 18 and over in the U.S., Belgium, Brazil, Colombia, France, Germany, the Philippines, South Africa, Spain and the U.K., J&J said. The company said about half of participants received the placebo but didn’t say how many participants were in the U.S.
J&J said Tuesday that an extra shot given two months after the first boosted antibody levels four to six times higher than observed after the single shot. It said a booster administered six months after the first shot initially increased antibody levels ninefold and continued to climb to 12-fold higher four weeks after the second shot. J&J released some of the six-month boosting data in August.
Neither that data nor the results released Tuesday have been peer reviewed or published in a scientific journal.
Have you seen this?
The company earlier this year said a large clinical trial showed that a single dose of its vaccine was 66% effective at protecting people from moderate to severe Covid-19.
J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection
Unless this virus turns really deadly I'm sticking with the first shot I got, I'm not getting any boosters...
...
Using Ancient Aliens reverse Occam's Razor paradigm, clearly aliens have instructed our governments to alter our immune systems to protect against common galactic diseases in the run up to disclosure.Hairdressers in parts of the UK are reporting clients having new allergic reactions, like rashes and burns, to hair dye after contracting coronavirus.
Scientists at Imperial College London are now researching how the disease could be reprogramming our immune system, in a similar way to other illnesses.
Well... at least he wont have worms... hehehehe...Joe Rogan Thinks Biden Faked His COVID-19 Booster Shot on Live TV
Joe Rogan’s streak of terrible COVID-19 takes continued this week when he baselessly suggested the White House faked President Joe Biden’s booster shot on live TV out of fear that he could have dropped dead in the moment.
After Biden took questions from reporters while he received his third dose of the Pfizer jab earlier this week, Rogan used his massively popular Spotify podcast to wonder aloud if it was a “real booster.”
When his guest, former CIA officer Mike Baker agreed, suggesting that it was merely “performance art,” Rogan dug deeper into his latest conspiracy theory.
“I don’t think they would take the chance,” the host said. “I think if they were going to give him a booster shot, the last thing they would do is give it to him live on television. What if he dies? What if he blacks out? What if he gets it and faints? Because people have had very bad reactions, like in the moment, for whatever reason.”
Earlier this year, the CDC reported 21 cases of anaphylaxis out of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine.
“Unless Kamala Harris talked him into it,” Rogan later joked—the implication being that she was trying to kill him so she could take over the job. “She’s like, go ahead, take it. Give him a double!”
While Rogan has repeatedly expressed skepticism around the COVID-19 vaccine and has not said whether or not he has received the shot himself, he confirmed that he took ivermectin—an anti-parasitic medication most commonly used for horse deworming—when he tested positive last month.
.